Chair’s Opening Remarks: The Breakthrough in mRNA/DNA LNP Innovations – Low N/P ratio, Nontoxic, and High Transfection Efficiency
Time: 8:30 am
day: Day One
Details:
- Overview of Me-Too LNPs with the conclusion that the Me-Too LNPs do not meet with the needs of rapidly developed genetic vaccines and therapeutics
- Share Cureport’s novel strategies of LNP innovations
- Compare the key differences between the novel LNP and Me-Too LNPs
- Share the in vitro and in vivo data of the novel LNPs
